Rose Pharma
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Founded Year
2003Stage
Series C | AliveTotal Raised
$10.85MLast Raised
$6M | 15 yrs agoAbout Rose Pharma
Rose Pharma is a developer of therapeutics for irritable bowel syndrome (IBS) and anorexia/cachexia associated with cancer and other major pathologies. The company's platform technology is based around glucagon-like peptide-1 (GLP-1), an endogenous peptide that has shown to stimulate insulin release from the pancreas while also reducing gastrointestinal motor activity. Its technology is designed to reduce contractions and muscular spasms associated with an IBS attack. [Keywords: hormone, insulin]
Rose Pharma Headquarters Location
Symbion Science Park Fruebjergvej 3
Copenhagen, 2100,
Denmark
45 353 87 997 0841
Expert Collections containing Rose Pharma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Rose Pharma is included in 2 Expert Collections, including Diabetes.
Diabetes
1,750 items
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Rose Pharma Patents
Rose Pharma has filed 2 patents.
The 3 most popular patent topics include:
- Diabetes
- G protein coupled receptors
- Peptide hormones
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/2/2020 | 7/13/2021 | G protein coupled receptors, Peptide hormones, Diabetes, Peptides, Proteins | Grant |
Application Date | 12/2/2020 |
|---|---|
Grant Date | 7/13/2021 |
Title | |
Related Topics | G protein coupled receptors, Peptide hormones, Diabetes, Peptides, Proteins |
Status | Grant |
When was Rose Pharma founded?
Rose Pharma was founded in 2003.
Where is Rose Pharma's headquarters?
Rose Pharma's headquarters is located at Symbion Science Park, Copenhagen.
What is Rose Pharma's latest funding round?
Rose Pharma's latest funding round is Series C.
How much did Rose Pharma raise?
Rose Pharma raised a total of $10.85M.
Who are the investors of Rose Pharma?
Investors of Rose Pharma include NB Capital, 123 Investment Managers, Capnova, Eli Lilly and Company, BioScience Managers and 5 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.